Glaukos Total Assets 2014-2024 | GKOS
- Glaukos total assets for the quarter ending December 31, 2024 were $0.975B, a 3.65% increase year-over-year.
- Glaukos total assets for 2024 were $0.975B, a 3.65% increase from 2023.
- Glaukos total assets for 2023 were $0.94B, a 6.18% decline from 2022.
- Glaukos total assets for 2022 were $1.002B, a 4.51% decline from 2021.
Glaukos Annual Total Assets (Millions of US $) |
|
---|---|
2024 | $975 |
2023 | $940 |
2022 | $1,002 |
2021 | $1,050 |
2020 | $1,006 |
2019 | $818 |
2018 | $207 |
2017 | $166 |
2016 | $134 |
2015 | $117 |
2014 | $26 |
2013 | $31 |
Glaukos Quarterly Total Assets (Millions of US $) |
|
---|---|
2024-12-31 | $975 |
2024-09-30 | $927 |
2024-06-30 | $920 |
2024-03-31 | $933 |
2023-12-31 | $940 |
2023-09-30 | $949 |
2023-06-30 | $957 |
2023-03-31 | $973 |
2022-12-31 | $1,002 |
2022-09-30 | $1,008 |
2022-06-30 | $1,031 |
2022-03-31 | $1,052 |
2021-12-31 | $1,050 |
2021-09-30 | $1,064 |
2021-06-30 | $1,044 |
2021-03-31 | $1,023 |
2020-12-31 | $1,006 |
2020-09-30 | $995 |
2020-06-30 | $996 |
2020-03-31 | $780 |
2019-12-31 | $818 |
2019-09-30 | $307 |
2019-06-30 | $302 |
2019-03-31 | $228 |
2018-12-31 | $207 |
2018-09-30 | $191 |
2018-06-30 | $171 |
2018-03-31 | $163 |
2017-12-31 | $166 |
2017-09-30 | $153 |
2017-06-30 | $146 |
2017-03-31 | $138 |
2016-12-31 | $134 |
2016-09-30 | $129 |
2016-06-30 | $124 |
2016-03-31 | $116 |
2015-12-31 | $117 |
2015-09-30 | $118 |
2015-06-30 | $128 |
2015-03-31 | $28 |
2014-12-31 | $26 |
2014-09-30 | $0 |
2014-06-30 | $0 |
2014-03-31 | $0 |
2013-12-31 | $31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $5.153B | $0.383B |
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Intuitive Surgical (ISRG) | United States | $171.942B | 78.88 |
Thermo Fisher Scientific (TMO) | United States | $161.378B | 19.56 |
Alcon (ALC) | Switzerland | $45.645B | 30.34 |
Edwards Lifesciences (EW) | United States | $42.050B | 27.30 |
IDEXX Laboratories (IDXX) | United States | $33.347B | 38.56 |
DexCom (DXCM) | United States | $26.887B | 41.56 |
IQVIA Holdings (IQV) | United States | $25.374B | 14.04 |
STERIS (STE) | Ireland | $21.834B | 24.97 |
Mettler-Toledo (MTD) | United States | $20.944B | 24.42 |
Waters (WAT) | United States | $19.099B | 27.04 |
SONOVA HOLDING (SONVY) | Switzerland | $17.304B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $13.878B | 14.16 |
Hologic (HOLX) | United States | $12.916B | 13.94 |
Sysmex ADR (SSMXY) | Japan | $11.847B | 0.00 |
Penumbra (PEN) | United States | $10.729B | 96.64 |
Globus Medical (GMED) | United States | $9.767B | 22.61 |
Masimo (MASI) | United States | $8.221B | 34.50 |
Teleflex (TFX) | United States | $6.004B | 9.24 |
Integer Holdings (ITGR) | United States | $4.081B | 22.07 |
TransMedics (TMDX) | United States | $2.985B | 87.37 |
PROCEPT BioRobotics (PRCT) | United States | $2.907B | 0.00 |
Veracyte (VCYT) | United States | $2.427B | 43.86 |
Nihon Kohden (NHNKY) | Japan | $2.081B | 11.37 |
LivaNova (LIVN) | United Kingdom | $1.934B | 11.74 |
Elekta AB (EKTAY) | Sweden | $1.891B | 17.00 |
Alphatec Holdings (ATEC) | United States | $1.522B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.18 |
Pulse Biosciences (PLSE) | United States | $1.193B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
Paragon 28 (FNA) | United States | $1.099B | 0.00 |
Artivion (AORT) | United States | $0.979B | 91.72 |
OPKO Health (OPK) | United States | $0.954B | 0.00 |
AxoGen (AXGN) | United States | $0.690B | 0.00 |
IRadimed (IRMD) | United States | $0.658B | 34.51 |
Mesa Laboratories (MLAB) | United States | $0.609B | 13.30 |
SiBone (SIBN) | United States | $0.588B | 0.00 |
RxSight (RXST) | United States | $0.584B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 9.21 |
OrthoPediatrics (KIDS) | United States | $0.510B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.508B | 0.00 |
Beta Bionics (BBNX) | United States | $0.483B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.406B | 0.00 |
Delcath Systems (DCTH) | United States | $0.389B | 0.00 |
AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
NeuroPace (NPCE) | United States | $0.351B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.342B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.315B | 16.87 |
Semler Scientific (SMLR) | United States | $0.312B | 6.62 |
Neuronetics (STIM) | United States | $0.247B | 0.00 |
Inogen (INGN) | United States | $0.183B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.181B | 0.00 |
908 Devices (MASS) | United States | $0.168B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.165B | 0.00 |
LENSAR (LNSR) | United States | $0.164B | 0.00 |
CVRx (CVRX) | United States | $0.163B | 0.00 |
Accuray (ARAY) | United States | $0.152B | 0.00 |
Sight Sciences (SGHT) | United States | $0.137B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.110B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.104B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.104B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.080B | 0.00 |
InspireMD (NSPR) | Israel | $0.079B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
Hyperfine (HYPR) | United States | $0.054B | 0.00 |
Positron (POSC) | United States | $0.051B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
Vicarious Surgical (RBOT) | United States | $0.032B | 0.00 |
Spectral AI (MDAI) | United States | $0.031B | 0.00 |
DarioHealth (DRIO) | United States | $0.031B | 0.00 |
Precision Optics (POCI) | United States | $0.030B | 0.00 |
Envoy Medical (COCH) | United States | $0.029B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
NexGel (NXGL) | United States | $0.022B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
PAVmed (PAVM) | United States | $0.012B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
Tenon Medical (TNON) | United States | $0.007B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.004B | 0.00 |
Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |